Short-term efficacy of early percutaneous cholecystostomy for pancreatitis and factors associated with recurrence and mortality

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 6

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Feb 14, 2025; 31(6): 101163
Published online Feb 14, 2025. doi: 10.3748/wjg.v31.i6.101163

Table 2 Pretreatment baseline data for both groups, n (%)

Variable	PC group (n = 54)	Conservative group (n = 29)	χ² value	P value
Sex			0.774	0.379
Male	30 (55.6)	19 (65.5)
Female	24 (44.4)	10 (34.5)
Charlson comorbidities
Congestive heart failure	2 (3.7)	0	-	0.540
Diabetes mellitus (no comorbidities)	14 (25.9)	8 (27.6)	0.027	0.870
Solid tumors (no metastases)	3 (5.6)	0	-	0.548
Cerebrovascular disease	11 (20.4)	2 (6.9)	1.673	0.196
Use of antimicrobials
Cephalosporins	19 (35.2)	9 (31)	0.145	0.703
Nitroimidazoles	30 (55.6)	13 (44.8)	0.870	0.351
Growth inhibitors	34 (63)	17 (58.6)	0.150	0.698
Proton pump inhibitors	25 (46.3)	12 (41.4)	0.185	0.667
Combinations	40 (74.1)	22 (75.9)	0.032	0.858

PC: Percutaneous cholecystostomy.

Citation: Yan X, Xie F, Zhao XD, Li L, Meng JX. Short-term efficacy of early percutaneous cholecystostomy for pancreatitis and factors associated with recurrence and mortality. World J Gastroenterol 2025; 31(6): 101163
URL: https://www.wjgnet.com/1007-9327/full/v31/i6/101163.htm
DOI: https://dx.doi.org/10.3748/wjg.v31.i6.101163

Yan X, Xie F, Zhao XD, Li L, Meng JX. Short-term efficacy of early percutaneous cholecystostomy for pancreatitis and factors associated with recurrence and mortality. World J Gastroenterol 2025; 31(6): 101163 [PMID: 39958444 DOI: 10.3748/wjg.v31.i6.101163]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.